COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00442650
Brief Title: Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

First Submitted : February 28, 2007
First Submitted that Met QC Criteria : March 1, 2007
First Posted : March 2, 2007 (Estimate)

Last Update Submitted that Met QC Criteria : November 18, 2016
Last Update Posted : November 21, 2016 (Estimate)